Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Finished Goods: 2012-2018

Historic Finished Goods for Lifecore Biomedical (LFCR) over the last 7 years, with May 2018 value amounting to $12.9 million.

  • Lifecore Biomedical's Finished Goods rose 7.93% to $13.9 million in Q4 2018 from the same period last year, while for Nov 2018 it was $13.9 million, marking a year-over-year increase of 7.93%. This contributed to the annual value of $12.9 million for FY2018, which is 28.42% up from last year.
  • Latest data reveals that Lifecore Biomedical reported Finished Goods of $12.9 million as of FY2018, which was up 28.42% from $10.0 million recorded in FY2017.
  • Over the past 5 years, Lifecore Biomedical's Finished Goods peaked at $13.3 million during FY2015, and registered a low of $10.0 million during FY2017.
  • Its 3-year average for Finished Goods is $11.7 million, with a median of $12.2 million in 2016.
  • Its Finished Goods has fluctuated over the past 5 years, first decreased by 17.67% in 2017, then rose by 28.42% in 2018.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Finished Goods stood at $11.1 million in 2014, then grew by 19.44% to $13.3 million in 2015, then decreased by 8.33% to $12.2 million in 2016, then fell by 17.67% to $10.0 million in 2017, then rose by 28.42% to $12.9 million in 2018.